How should moderate hyponatremia be corrected in children using oral table salt (sodium chloride)?

Oral Sodium Chloride for Moderate Hyponatremia in Children

For moderate hyponatremia (sodium 130-134 mEq/L) in children, oral sodium chloride supplementation at 1-2 g/day is safe and effective for gradual correction, but symptomatic or severe hyponatremia requires immediate intravenous hypertonic saline (3% NaCl) as 2 mL/kg boluses (maximum 100 mL) to prevent neurological injury. 1, 2

Defining the Clinical Context

Moderate hyponatremia is defined as serum sodium <130 mEq/L but ≥125 mEq/L 3. The critical distinction is whether symptoms are present:

• Asymptomatic moderate hyponatremia: Oral sodium chloride is appropriate 4, 5
• Symptomatic hyponatremia (altered mental status, seizures, headache, nausea): This is a medical emergency requiring IV hypertonic saline, never fluid restriction alone 1, 2

Oral Sodium Chloride Dosing Protocol

For asymptomatic moderate hyponatremia, administer oral sodium chloride 1-2 g/day divided into multiple doses 4:

• Children under 9 years: Consult physician for specific dosing; general range 1-2 g/day based on clinical trial data 6, 4
• Children 9-18 years: 936 mg (4 mL of 23.4% solution) per dose, adjustable based on serum sodium monitoring 6
• Frequency: Divide total daily dose into 2-3 administrations to maintain steady sodium intake 4

The concentrated oral solution (23.4% sodium chloride, 4 mEq/mL) provides 936 mg sodium chloride per 4 mL serving 6.

Evidence Supporting Oral Salt Supplementation

A 2024 randomized controlled trial in 120 children demonstrated that daily oral sodium chloride supplementation (1-2 g/day for 12 weeks) significantly reduced hyponatremia incidence (4/60 vs 14/60, p=0.01) and maintained higher serum sodium levels (136.5 vs 135.4 mEq/L, p=0.01) 4. However, this study showed no significant reduction in symptomatic or severe hyponatremia, indicating oral supplementation is preventive rather than therapeutic for acute symptomatic cases 4.

In premature infants, sodium supplementation at 4 mEq/kg/day prevented late-onset hyponatremia (p=0.012) and improved weight gain without increasing morbidities 7. This supports the safety profile of oral sodium supplementation in vulnerable pediatric populations.

Monitoring Requirements

Serum sodium must be checked every 24-48 hours during oral supplementation to ensure:

• Gradual correction rate not exceeding 8-10 mEq/L per 24 hours 5, 8
• Prevention of overcorrection, which can cause osmotic demyelination syndrome 1, 8
• Assessment of treatment response and need for therapy adjustment 4

Urine sodium and osmolality should be measured to differentiate SIADH from cerebral salt wasting, as treatment differs fundamentally 9, 5:

• SIADH: High urine sodium (>40 mEq/L), high urine osmolality, euvolemia
• Cerebral salt wasting: High urine sodium, high urine output, hypovolemia requiring volume replacement 9

Adjunctive Measures

Combine oral sodium chloride with adequate dietary solute intake (protein and salt) and initial fluid restriction of 500 mL/day below maintenance, adjusted based on serum sodium response 5. Nearly half of SIADH patients do not respond to fluid restriction alone, making sodium supplementation essential 5.

For patients with ongoing free water retention despite oral supplementation, oral urea (0.25-0.5 g/kg/day) is considered very effective and safe as second-line therapy 5, 10.

Critical Pitfalls to Avoid

Never use fluid restriction alone for symptomatic hyponatremia 1, 2. This is inadequate and dangerous, as symptomatic patients require immediate active correction with hypertonic saline.

Do not use hypotonic IV fluids (0.45% or 0.2% saline) in hospitalized children, as these increase hyponatremia risk by >5-fold for moderate hyponatremia 3. Isotonic fluids (0.9% NaCl) should be standard for maintenance IV therapy 3, 1, 2.

Recognize high-risk patients who may develop hyponatremic encephalopathy at mildly hyponatremic values (sodium 125-130 mEq/L): those with hypoxia, CNS disease, postoperative state, or pulmonary disease 1, 2. These patients warrant more aggressive monitoring and lower threshold for IV therapy.

Avoid overcorrection by being prepared to administer hypotonic fluids or desmopressin if sodium rises too rapidly (>10 mEq/L in 24 hours or >18 mEq/L in 48 hours) 5, 8.

When to Escalate to IV Therapy

Immediately switch to IV 3% hypertonic saline if 1, 2:

• Any neurological symptoms develop (altered mental status, seizures, severe headache, vomiting)
• Serum sodium drops below 125 mEq/L
• Patient cannot tolerate oral intake
• No improvement in serum sodium after 48 hours of oral therapy

The intermittent bolus approach (3% NaCl 2 mL/kg, maximum 100 mL, repeated as needed) rapidly reverses CNS symptoms while minimizing overcorrection risk 1.

Special Populations

Cerebral salt wasting (seen with CNS injury, seizures, hydrocephalus) requires volume-for-volume urine replacement with 0.9% or 3% sodium chloride, not fluid restriction 9. These patients have true salt wasting with hypovolemia, elevated atrial natriuretic hormone, and decreased aldosterone 9.

Patients on oxcarbazepine benefit from prophylactic oral sodium chloride 1-2 g/day to prevent drug-induced hyponatremia, though this does not eliminate risk of severe hyponatremia 4.